nach oben

Erschienen in:

18.09.2023 | Global Health Services Research

Social Determinants of Cancer Disparities

verfasst von: Georgia Syrnioti, MD, MSc, Claire M. Eden, MD, Josh A. Johnson, MD, Chase Alston, MHS, Antonia Syrnioti, MD, Lisa A. Newman, MD, MPH

Erschienen in: Annals of Surgical Oncology | Ausgabe 13/2023

Einloggen, um Zugang zu erhalten

Abstract

Cancer is a major public health issue that is associated with significant morbidity and mortality across the globe. At its root, cancer represents a genetic aberration, but socioeconomic, environmental, and geographic factors contribute to different cancer outcomes for selected population subsets. The disparities in the delivery of healthcare affect all aspects of cancer management from early prevention to end-of-life care. In an effort to address the inequality in the delivery of healthcare among socioeconomically disadvantaged populations, the World Health Organization defined social determinants of health (SDOH) as conditions in which people are born, live, work, and age. These factors play a significant role in the disproportionate cancer burden among different population groups. SDOH are associated with disparities in risk factor burden, screening modalities, diagnostic testing, treatment options, and quality of life of patients with cancer. The purpose of this article is to describe a more holistic and integrated approach to patients with cancer and address the disparities that are derived from their socioeconomic background.

Cancer Facts and Figures. 2023. https://www.cancer.org/research/cancer-facts-statistics/all-cancer-facts-figures/2023-cancer-facts-figures.html. Accessed 11 Mar 2023.

Shen J, Fuemmeler BF, Guan Y, Zhao H. Association of allostatic load and all cancer risk in the SWAN cohort. Cancers. 2022;14(13):3044.CrossRefPubMedPubMedCentral

Akinyemiju T, Wilson LE, Deveaux A, et al. Association of allostatic load with all-cause and cancer mortality by race and body mass index in the REGARDS cohort. Cancers. 2020;12(6):1695.CrossRefPubMedPubMedCentral

Irwin A, Valentine N, Brown C, et al. The commission on social determinants of health: tackling the social roots of health inequities. PLoS Med. 2006;3(6):e106. https://doi.org/10.1371/journal.pmed.0030106.CrossRefPubMedPubMedCentral

Lariscy JT, Hummer RA, Rogers RG. Cigarette smoking and all-cause and cause-specific adult mortality in the United States. Demography. 2018;55(5):1855–85. https://doi.org/10.1007/s13524-018-0707-2.CrossRefPubMed

Irvin Vidrine J, Reitzel LR, Wetter DW. The role of tobacco in cancer health disparities. Curr Oncol Rep. 2009;11(6):475–81. https://doi.org/10.1007/s11912-009-0064-9.CrossRefPubMed

Cornelius ME, Loretan CG, Wang TW, Jamal A, Homa DM. Tobacco product use among adults—United States, 2020. MMWR Morb Mortal Wkly Rep. 2022;71(11):397–405. https://doi.org/10.15585/mmwr.mm7111a1.CrossRefPubMedPubMedCentral

Fedele DA, Tooley E, Busch A, McQuaid EL, Hammond SK, Borrelli B. Comparison of secondhand smoke exposure in minority and nonminority children with asthma. Health Psychol. 2016;35(2):115–22. https://doi.org/10.1037/hea0000220.CrossRefPubMed

Tsai J, Homa DM, Gentzke AS, et al. Exposure to secondhand smoke among nonsmokers—United States, 1988–2014. MMWR Morb Mortal Wkly Rep. 2018;67(48):1342–6. https://doi.org/10.15585/mmwr.mm6748a3.CrossRefPubMedPubMedCentral

10.

Ryan BM. Lung cancer health disparities. Carcinogenesis. 2018;39(6):741–51. https://doi.org/10.1093/carcin/bgy047.CrossRefPubMedPubMedCentral

11.

Pooler JA, Hartline-Grafton H, DeBor M, Sudore RL, Seligman HK. Food insecurity: a key social determinant of health for older adults. J Am Geriatr Soc. 2019;67(3):421–4. https://doi.org/10.1111/jgs.15736.CrossRefPubMed

12.

Household Food Security in the United States in 2021. https://www.ers.usda.gov/publications/pub-details/?pubid=104655. Accessed 11 Mar 2023.

13.

Camacho-Rivera M, Islam JY, Rodriguez DR, Vidot DC, Bailey Z. Food insecurity disparities and mental health impacts among cancer survivors during the COVID-19 pandemic. Health Equity. 2022;6(1):729–37. https://doi.org/10.1089/heq.2021.0120.CrossRefPubMedPubMedCentral

14.

Coughlin SS. Social determinants of health and cancer survivorship. J Environ Health Sci. 2021;7(1):11–5.PubMedPubMedCentral

15.

Juon HS, Hong A, Pimpinelli M, Rojulpote M, McIntire R, Barta JA. Racial disparities in occupational risks and lung cancer incidence: analysis of the national lung screening trial. Prev Med. 2021;143:106355. https://doi.org/10.1016/j.ypmed.2020.106355.CrossRefPubMed

16.

Collatuzzo G, Teglia F, Boffetta P. Role of occupation in shaping cancer disparities. Cancers. 2022;14(17):4259. https://doi.org/10.3390/cancers14174259.CrossRefPubMedPubMedCentral

17.

Letašiová S, Medve’ová A, Šovčíková A, et al. Bladder cancer, a review of the environmental risk factors. Environ Health. 2012;11(Suppl 1):S11. https://doi.org/10.1186/1476-069X-11-S1-S11.CrossRefPubMedPubMedCentral

18.

Kiriluk KJ, Prasad SM, Patel AR, Steinberg GD, Smith ND. Bladder cancer risk from occupational and environmental exposures. Urol Oncol. 2012;30(2):199–211. https://doi.org/10.1016/j.urolonc.2011.10.010.CrossRefPubMed

19.

Stierman B, et al. National Health and Nutrition Examination Survey 2017–March 2020 prepandemic data files development of files and prevalence estimates for selected health outcomes. National Health Statistics Reports, Series: NHSR No. 158. https://doi.org/10.15620/cdc:106273.

20.

De Pergola G, Silvestris F. Obesity as a major risk factor for cancer. J Obes. 2013;2013:291546. https://doi.org/10.1155/2013/291546.CrossRefPubMedPubMedCentral

21.

Lauby-Secretan B, Scoccianti C, Loomis D, et al. Body fatness and cancer–viewpoint of the IARC Working Group. N Engl J Med. 2016;375(8):794–8. https://doi.org/10.1056/NEJMsr1606602.CrossRefPubMedPubMedCentral

22.

Elreda L, Kim A, Malik M. Mitigating breast cancer disparities by addressing the obesity epidemic. Curr Breast Cancer Rep. 2022;14:168–73.CrossRefPubMedPubMedCentral

23.

Wen M, Fan JX, Kowaleski-Jones L, Wan N. Rural–urban disparities in obesity prevalence among working age adults in the United States: exploring the mechanisms. Am J Health Promot. 2018;32(2):400–8. https://doi.org/10.1177/0890117116689488.CrossRefPubMed

24.

Okobi OE, Ajayi OO, Okobi TJ, et al. The burden of obesity in the rural adult population of America. Cureus. 2021;13(6):e15770. https://doi.org/10.7759/cureus.15770.CrossRefPubMedPubMedCentral

25.

Contreras DA, Martoccio TL, Brophy-Herb HE, et al. Rural–urban differences in body mass index and obesity-related behaviors among low-income preschoolers. J Public Health (Oxf). 2021;43(4):e637–44. https://doi.org/10.1093/pubmed/fdaa162.CrossRefPubMed

26.

Hill JL, You W, Zoellner JM. Disparities in obesity among rural and urban residents in a health disparate region. BMC Public Health. 2014;14:1051. https://doi.org/10.1186/1471-2458-14-1051.CrossRefPubMedPubMedCentral

27.

Ohm JE. Environmental exposures, the epigenome, and African American women’s health. J Urban Health. 2019;96(Suppl 1):50–6. https://doi.org/10.1007/s11524-018-00332-2.CrossRefPubMed

28.

Guidi J, Lucente M, Sonino N, Fava GA. Allostatic load and its impact on health: a systematic review. Psychother Psychosom. 2021;90(1):11–27. https://doi.org/10.1159/000510696.CrossRefPubMed

29.

Mathew A, Doorenbos AZ, Li H, Jang MK, Park CG, Bronas UG. Allostatic load in cancer: a systematic review and mini meta-analysis. Biol Res Nurs. 2021;23(3):341–61. https://doi.org/10.1177/1099800420969898.CrossRefPubMed

30.

Rodriquez EJ, Kim EN, Sumner AE, Nápoles AM, Pérez-Stable EJ. Allostatic load: importance, markers, and score determination in minority and disparity populations. J Urban Health. 2019;96(Suppl 1):3–11. https://doi.org/10.1007/s11524-019-00345-5.CrossRefPubMedPubMedCentral

31.

Duru OK, Harawa NT, Kermah D, Norris KC. Allostatic load burden and racial disparities in mortality. J Natl Med Assoc. 2012;104(1–2):89–95. https://doi.org/10.1016/s0027-9684(15)30120-6.CrossRefPubMed

32.

Geronimus AT, Hicken M, Keene D, Bound J. “Weathering” and age patterns of allostatic load scores among blacks and whites in the United States. Am J Public Health. 2006;96(5):826–33. https://doi.org/10.2105/AJPH.2004.060749.CrossRefPubMedPubMedCentral

33.

Schulz AJ, Mentz G, Lachance L, Johnson J, Gaines C, Israel BA. Associations between socioeconomic status and allostatic load: effects of neighborhood poverty and tests of mediating pathways. Am J Public Health. 2012;102(9):1706–14. https://doi.org/10.2105/AJPH.2011.300412.CrossRefPubMedPubMedCentral

34.

Xing CY, Doose M, Qin B, et al. Prediagnostic allostatic load as a predictor of poorly differentiated and larger sized breast cancers among Black women in the women’s circle of health follow-up study. Cancer Epidemiol Biomarkers Prev. 2020;29(1):216–24. https://doi.org/10.1158/1055-9965.EPI-19-0712.CrossRefPubMed

35.

Obeng-Gyasi S, Li Y, Carson WE, et al. Association of allostatic load with overall mortality among patients with metastatic non-small cell lung cancer. JAMA Netw Open. 2022;5(7):e2221626. https://doi.org/10.1001/jamanetworkopen.2022.21626. (published correction appears in JAMA Netw Open. 2023 Mar 1;6(3):e236766).CrossRefPubMedPubMedCentral

36.

Moleyar-Narayana P, Ranganathan S. Cancer screening. [Updated 2023 Jan 23]. Treasure Island (FL): StatPearls Publishing; 2023. Available from: https://www.ncbi.nlm.nih.gov/books/NBK563138/.

37.

Benavidez GA, Zgodic A, Zahnd WE, Eberth JM. Disparities in meeting USPSTF breast, cervical, and colorectal cancer screening guidelines among women in the United States. Prev Chronic Dis. 2021;18:200315. https://doi.org/10.5888/pcd18.200315.CrossRef

38.

Liu D, Schuchard H, Burston B, Yamashita T, Albert S. Interventions to reduce healthcare disparities in cancer screening among minority adults: a systematic review. J Racial Ethn Health Disparities. 2021;8(1):107–26. https://doi.org/10.1007/s40615-020-00763-1.CrossRefPubMed

39.

Colorectal Cancer Facts and Figures, American Cancer Society. https://www.cancer.org/research/cancer-facts-statistics/colorectal-cancer-facts-figures.html. Accessed 11 Mar 2023.

40.

Montiel Ishino FA, Odame EA, Villalobos K, et al. A national study of colorectal cancer survivorship disparities: a latent class analysis using SEER (surveillance, epidemiology, and end results) registries. Front Public Health. 2021;9:628022. https://doi.org/10.3389/fpubh.2021.628022.CrossRefPubMedPubMedCentral

41.

Cole AM, Jackson JE, Doescher M. Urban-rural disparities in colorectal cancer screening: cross-sectional analysis of 1998–2005 data from the Centers for Disease Control’s Behavioral Risk Factor Surveillance Study. Cancer Med. 2012;1(3):350–6. https://doi.org/10.1002/cam4.40.CrossRefPubMedPubMedCentral

42.

Centers for Disease Control and Prevention. QuickStats: colorectal cancer screening among adults aged 50–75 years, by race/ethnicity—National Health Interview Survey, United States, 2000–2015. MMWR Morb Mortal Wkly Rep. 2016;65:1042. https://doi.org/10.15585/mmwr.mm6538a6external.CrossRef

43.

So WKW, Law BMH, Choi KC, Chan DNS, Chan CWH. A family-based multimedia intervention to enhance the uptake of colorectal cancer screening among older South Asian adults in Hong Kong: a study protocol for a cluster randomized controlled trial. BMC Public Health. 2019;19(1):652. https://doi.org/10.1186/s12889-019-6995-7. (published correction appears in BMC Public Health. 2021 Dec 3;21(1):2205).CrossRefPubMedPubMedCentral

44.

Kim SJ, Glassgow AE, Watson KS, Molina Y, Calhoun EA. Gendered and racialized social expectations, barriers, and delayed breast cancer diagnosis. Cancer. 2018;124(22):4350–7. https://doi.org/10.1002/cncr.31636.CrossRefPubMed

45.

Breast Cancer Facts and Figures, American Cancer Society. https://www.cancer.org/research/cancer-facts-statistics/breast-cancer-facts-figures.html. Accessed 11 Mar 2023.

46.

Press R, Carrasquillo O, Sciacca RR, Giardina EG. Racial/ethnic disparities in time to follow-up after an abnormal mammogram. J Womens Health (Larchmt). 2008;17(6):923–30. https://doi.org/10.1089/jwh.2007.0402.CrossRefPubMed

47.

Henderson LM, O’Meara ES, Haas JS, et al. The role of social determinants of health in self-reported access to health care among women undergoing screening mammography. J Womens Health (Larchmt). 2020;29(11):1437–46. https://doi.org/10.1089/jwh.2019.8267.CrossRefPubMed

48.

Scarinci IC, Garcia FA, Kobetz E, et al. Cervical cancer prevention: new tools and old barriers. Cancer. 2010;116(11):2531–42. https://doi.org/10.1002/cncr.25065.CrossRefPubMed

49.

Cervical Cancer Statistics, Centers for Disease Control and Prevention. https://www.cdc.gov/cancer/cervical/statistics/index.htm. Accessed 11 Mar 2023.

50.

Cohen CM, Wentzensen N, Castle PE, et al. Racial and ethnic disparities in cervical cancer incidence, survival, and mortality by histologic subtype. J Clin Oncol. 2023;41(5):1059–68. https://doi.org/10.1200/JCO.22.01424.CrossRefPubMed

51.

Jemal A, Simard EP, Dorell C, et al. Annual report to the nation on the status of cancer, 1975–2009, featuring the burden and trends in human papillomavirus (HPV)-associated cancers and HPV vaccination coverage levels. J Natl Cancer Inst. 2013;105(3):175–201. https://doi.org/10.1093/jnci/djs491.CrossRefPubMedPubMedCentral

52.

Benard VB, Howe W, Royalty J, Helsel W, Kammerer W, Richardson LC. Timeliness of cervical cancer diagnosis and initiation of treatment in the National Breast and Cervical Cancer Early Detection Program. J Womens Health (Larchmt). 2012;21(7):776–82. https://doi.org/10.1089/jwh.2011.3224.CrossRefPubMed

53.

Yu L, Sabatino SA, White MC. Rural–urban and racial/ethnic disparities in invasive cervical cancer incidence in the United States, 2010–2014. Prev Chronic Dis. 2019;16:E70. https://doi.org/10.5888/pcd16.180447.CrossRefPubMedPubMedCentral

54.

McDonald YJ, Goldberg DW, Scarinci IC, et al. Health service accessibility and risk in cervical cancer prevention: comparing rural versus nonrural residence in New Mexico. J Rural Health. 2017;33(4):382–92. https://doi.org/10.1111/jrh.12202.CrossRefPubMed

55.

Lung cancer: screening. Force, US preventive services task. 2021. https://www.uspreventiveservicestaskforce.org/uspstf/recommendation/lung-cancer-screening. Accessed 11 Mar 2023.

56.

National Lung Screening Trial Research Team, Aberle DR, Adams AM, et al. Reduced lung-cancer mortality with low-dose computed tomographic screening. N Engl J Med. 2011;365(5):395–409. https://doi.org/10.1056/NEJMoa1102873.CrossRef

57.

State of Lung Cancer, American Lung Association. 2022. https://www.lung.org/getmedia/647c433b-4cbc-4be6-9312-2fa9a449d489/solc-2022-print-report. Accessed 11 Mar 2023.

58.

Haddad DN, Sandler KL, Henderson LM, Rivera MP, Aldrich MC. Disparities in lung cancer screening: a review. Ann Am Thorac Soc. 2020;17(4):399–405. https://doi.org/10.1513/AnnalsATS.201907-556CME.CrossRefPubMedPubMedCentral

59.

Zettler ME, Feinberg BA, Jeune-Smith Y, Gajra A. Impact of social determinants of health on cancer care: a survey of community oncologists. BMJ Open. 2021;11(10):e049259. https://doi.org/10.1136/bmjopen-2021-049259.CrossRefPubMedPubMedCentral

60.

Levit LA, Byatt L, Lyss AP, et al. Closing the rural cancer care gap: three institutional approaches. JCO Oncol Pract. 2020;16(7):422–30. https://doi.org/10.1200/OP.20.00174.CrossRefPubMed

61.

Henley SJ, Jemal A. Rural cancer control: bridging the chasm in geographic health inequity. Cancer Epidemiol Biomark Prev. 2018;27(11):1248–51. https://doi.org/10.1158/1055-9965.EPI-18-0807.CrossRef

62.

U.S. Cancer Statistics Working Group. U.S. cancer statistics data visualizations tool, based on 2022 submission data (1999–2020): U.S. Department of Health and Human Services, Centers for Disease Control and Prevention and National Cancer Institute. www.cdc.gov/cancer/dataviz. released in June 2023.

63.

Yabroff KR, Han X, Zhao J, Nogueira L, Jemal A. Rural cancer disparities in the United States: a multilevel framework to improve access to care and patient outcomes. JCO Oncol Pract. 2020;16(7):409–13. https://doi.org/10.1200/OP.20.00352.CrossRefPubMed

64.

Bach PB, Schrag D, Brawley OW, Galaznik A, Yakren S, Begg CB. Survival of blacks and whites after a cancer diagnosis. JAMA. 2002;287(16):2106–13. https://doi.org/10.1001/jama.287.16.2106.CrossRefPubMed

65.

Gehlert S, Hudson D, Sacks T. A Critical theoretical approach to cancer disparities: breast cancer and the social determinants of health. Front Public Health. 2021;9:674736. https://doi.org/10.3389/fpubh.2021.674736.CrossRefPubMedPubMedCentral

66.

Wheeler SB, Reeder-Hayes KE, Carey LA. Disparities in breast cancer treatment and outcomes: biological, social, and health system determinants and opportunities for research. Oncologist. 2013;18(9):986–93. https://doi.org/10.1634/theoncologist.2013-0243.CrossRefPubMedPubMedCentral

67.

Williams DR, Mohammed SA, Shields AE. Understanding and effectively addressing breast cancer in African American women: unpacking the social context. Cancer. 2016;122(14):2138–49. https://doi.org/10.1002/cncr.29935.CrossRefPubMed

68.

Stabellini N, Cullen J, Cao L, et al. Racial disparities in breast cancer treatment patterns and treatment related adverse events. Sci Rep. 2023;13(1):1233. https://doi.org/10.1038/s41598-023-27578-4.CrossRefPubMedPubMedCentral

69.

Cho B, Han Y, Lian M, et al. Evaluation of racial/ethnic differences in treatment and mortality among women with triple-negative breast cancer. JAMA Oncol. 2021;7(7):1016–23. https://doi.org/10.1001/jamaoncol.2021.1254.CrossRefPubMed

70.

Neroda P, Hsieh MC, Wu XC, et al. Racial disparity and social determinants in receiving timely surgery among stage I–IIIA non-small cell lung cancer patients in a U.S. Southern state. Front Public Health. 2021;9:662876. https://doi.org/10.3389/fpubh.2021.662876.CrossRefPubMedPubMedCentral

71.

Ko NY, Hong S, Winn RA, Calip GS. Association of insurance status and racial disparities with the detection of early-stage breast cancer. JAMA Oncol. 2020;6(3):385–92. https://doi.org/10.1001/jamaoncol.2019.5672.CrossRefPubMedPubMedCentral

72.

Sineshaw HM, Ng K, Flanders WD, Brawley OW, Jemal A. Factors that contribute to differences in survival of Black vs white patients with colorectal cancer. Gastroenterology. 2018;154(4):906-915.e7. https://doi.org/10.1053/j.gastro.2017.11.005.CrossRefPubMed

73.

Amiri S, Greer MD, Muller CJ, et al. Disparities in access to radiation therapy by race and ethnicity in the United States with focus on American Indian/Alaska Native People. Value Health. 2022;25(12):1929–38. https://doi.org/10.1016/j.jval.2022.03.025.CrossRefPubMed

74.

Gardner U Jr, McClelland S 3rd, Deville C Jr. Disparities in the utilization of radiation therapy for prostate cancer in the United States: a comprehensive review. Adv Radiat Oncol. 2022;7(4):100943. https://doi.org/10.1016/j.adro.2022.100943.CrossRefPubMedPubMedCentral

75.

Sutton AL, Hurtado-de-Mendoza A, Quillin J, et al. Reducing disparities in receipt of genetic counseling for underserved women at risk of hereditary breast and ovarian cancer. J Womens Health (Larchmt). 2020;29(8):1131–5. https://doi.org/10.1089/jwh.2019.7984.CrossRefPubMed

76.

Kurian AW, Ward KC, Howlader N, et al. Genetic testing and results in a population-based cohort of breast cancer patients and ovarian cancer patients. J Clin Oncol. 2019;37(15):1305–15. https://doi.org/10.1200/JCO.18.01854.CrossRefPubMedPubMedCentral

77.

Lin J, Sharaf RN, Saganty R, et al. Achieving universal genetic assessment for women with ovarian cancer: Are we there yet? A systematic review and meta-analysis. Gynecol Oncol. 2021;162(2):506–16. https://doi.org/10.1016/j.ygyno.2021.05.011.CrossRefPubMedPubMedCentral

78.

Bellaiche MMJ, Fan W, Walbert HJ, et al. Disparity in access to oncology precision care: a geospatial analysis of driving distances to genetic counselors in the U.S. Front Oncol. 2021;11:689927. https://doi.org/10.3389/fonc.2021.689927.CrossRefPubMedPubMedCentral

79.

Haque W, Verma V, Butler EB, Teh BS. Racial and socioeconomic disparities in the delivery of immunotherapy for metastatic melanoma in the United States. J Immunother. 2019;42(6):228–35. https://doi.org/10.1097/CJI.0000000000000264.CrossRefPubMed

80.

Verma V, Haque W, Cushman TR, et al. Racial and insurance-related disparities in delivery of immunotherapy-type compounds in the United States. J Immunother. 2019;42(2):55–64. https://doi.org/10.1097/CJI.0000000000000253.CrossRefPubMed

81.

Ahn JC, Lauzon M, Luu M, et al. Racial and ethnic disparities in early treatment with immunotherapy for advanced HCC in the United States. Hepatology. 2022;76(6):1649–59. https://doi.org/10.1002/hep.32527.CrossRefPubMed

82.

Deng W, Wang Y, Yang M, Liu X, Yang Z, Jiang W. Racial disparities in time to treatment initiation for stage IV non-small cell lung cancer patients receiving immunotherapy. Int J Radiat Oncol Biol Phys. 2020;108(3):e154. https://doi.org/10.1016/j.ijrobp.2020.07.1332.CrossRef

83.

Loree JM, Anand S, Dasari A, et al. Disparity of race reporting and representation in clinical trials leading to cancer drug approvals from 2008 to 2018. JAMA Oncol. 2019;5(10):e191870. https://doi.org/10.1001/jamaoncol.2019.1870.CrossRefPubMedPubMedCentral

84.

Alegria M, Sud S, Steinberg BE, Gai N, Siddiqui A. Reporting of participant race, sex, and socioeconomic status in randomized clinical trials in general medical journals, 2015 vs 2019. JAMA Netw Open. 2021;4(5):e2111516. https://doi.org/10.1001/jamanetworkopen.2021.11516.CrossRefPubMedPubMedCentral

85.

Unger JM, Moseley AB, Cheung CK, et al. Persistent disparity: socioeconomic deprivation and cancer outcomes in patients treated in clinical trials. J Clin Oncol. 2021;39(12):1339–48. https://doi.org/10.1200/JCO.20.02602.CrossRefPubMedPubMedCentral

86.

Ashing-Giwa K, Ganz PA, Petersen L. Quality of life of African-American and white long term breast carcinoma survivors. Cancer. 1999;85(2):418–26. https://doi.org/10.1002/(sici)1097-0142(19990115)85:2%3c418::aid-cncr20%3e3.0.co;2-9. (published correction appears in Cancer 1999 Aug 15;86(4):732–3).CrossRefPubMed

87.

Ashing-Giwa K. Quality of life and psychosocial outcomes in long-term survivors of breast cancer. J Psychosoc Oncol. 1999;17(3–4):47–62. https://doi.org/10.1300/J077v17n03_03.CrossRef

88.

Samuel CA, Mbah OM, Elkins W, et al. Calidad de vida: a systematic review of quality of life in Latino cancer survivors in the USA. Qual Life Res. 2020;29(10):2615–30. https://doi.org/10.1007/s11136-020-02527-0.CrossRefPubMedPubMedCentral

89.

McDougall JA, Blair CK, Wiggins CL, et al. Socioeconomic disparities in health-related quality of life among colorectal cancer survivors. J Cancer Surv. 2019;13(3):459–67. https://doi.org/10.1007/s11764-019-00767-9.CrossRef

90.

Ramasubbu SK, Pasricha RK, Nath UK, Rawat VS, Das B. Quality of life and factors affecting it in adult cancer patients undergoing cancer chemotherapy in a tertiary care hospital. Cancer Rep (Hoboken). 2021;4(2):e1312. https://doi.org/10.1002/cnr2.1312.CrossRefPubMed

91.

Gany F, Leng J, Ramirez J, et al. Health-related quality of life of food-insecure ethnic minority patients with cancer. J Oncol Pract. 2015;11(5):396–402. https://doi.org/10.1200/JOP.2015.003962. (published correction appears in J Oncol Pract. 2016 Jan;12(1):98).CrossRefPubMedPubMedCentral

92.

Burris JL, Andrykowski M. Disparities in mental health between rural and nonrural cancer survivors: a preliminary study. Psychooncology. 2010;19(6):637–45. https://doi.org/10.1002/pon.1600.CrossRefPubMedPubMedCentral

93.

Noonan D, LeBlanc M, Conley C, et al. Quality of life and impact of cancer: differences in rural and nonrural non-Hodgkin’s lymphoma survivors. J Rural Health. 2020;36(4):536–42. https://doi.org/10.1111/jrh.12420.CrossRefPubMedPubMedCentral

94.

Lai YJ, Chen YY, Ko MC, et al. Low socioeconomic status associated with lower utilization of hospice care services during end-of-life treatment in patients with cancer: a population-based cohort study. J Pain Symptom Manag. 2020;60(2):309-315.e1. https://doi.org/10.1016/j.jpainsymman.2020.03.015.CrossRef

95.

Grande GE, McKerral A, Todd CJ. Which cancer patients are referred to hospital at home for palliative care? Palliat Med. 2002;16(2):115–23. https://doi.org/10.1191/0269216302pm519oa.CrossRefPubMed

96.

Charlton M, Schlichting J, Chioreso C, Ward M, Vikas P. Challenges of rural cancer care in the United States. Oncology (Williston Park). 2015;29(9):633–40.PubMed

97.

Klop HT, de Veer AJE, van Dongen SI, Francke AL, Rietjens JAC, Onwuteaka-Philipsen BD. Palliative care for homeless people: a systematic review of the concerns, care needs and preferences, and the barriers and facilitators for providing palliative care. BMC Palliat Care. 2018;17(1):67. https://doi.org/10.1186/s12904-018-0320-6.CrossRefPubMedPubMedCentral

98.

Griggs JJ. Disparities in palliative care in patients with cancer. J Clin Oncol. 2020;38(9):974–9. https://doi.org/10.1200/JCO.19.02108.CrossRefPubMed

99.

Abodunrin F, Adeoye O, Krishnan M, Silberstein PT, Tupper C. Socioeconomic disparities in the receipt of palliative care in biliary tract cancers. J Clin Oncol. 2022;40(28_suppl):80–80. https://doi.org/10.1200/JCO.2022.40.28_suppl.080.CrossRef

100.

Azhar A, Yennurajalingam S, Ramu A, et al. Timing of referral and characteristics of uninsured, Medicaid, and insured patients referred to the outpatient supportive care center at a comprehensive cancer center. J Pain Symptom Manag. 2018;55(3):973–8. https://doi.org/10.1016/j.jpainsymman.2017.10.025.CrossRef

Titel: Social Determinants of Cancer Disparities
verfasst von: Georgia Syrnioti, MD, MSc
Claire M. Eden, MD
Josh A. Johnson, MD
Chase Alston, MHS
Antonia Syrnioti, MD
Lisa A. Newman, MD, MPH
Publikationsdatum: 18.09.2023
Verlag: Springer International Publishing
Erschienen in: Annals of Surgical Oncology / Ausgabe 13/2023
Print ISSN: 1068-9265
Elektronische ISSN: 1534-4681
DOI: https://doi.org/10.1245/s10434-023-14200-0

Neu im Fachgebiet Chirurgie

Vorsicht, erhöhte Blutungsgefahr nach PCI!

10.05.2024 Koronare Herzerkrankung Nachrichten

Nach PCI besteht ein erhöhtes Blutungsrisiko, wenn die Behandelten eine verminderte linksventrikuläre Ejektionsfraktion aufweisen. Das Risiko ist umso höher, je stärker die Pumpfunktion eingeschränkt ist.

Darf man die Behandlung eines Neonazis ablehnen?

08.05.2024 Gesellschaft Nachrichten

In einer Leseranfrage in der Zeitschrift Journal of the American Academy of Dermatology möchte ein anonymer Dermatologe bzw. eine anonyme Dermatologin wissen, ob er oder sie einen Patienten behandeln muss, der eine rassistische Tätowierung trägt.

Deutlich weniger Infektionen: Wundprotektoren schützen!

08.05.2024 Postoperative Wundinfektion Nachrichten

Der Einsatz von Wundprotektoren bei offenen Eingriffen am unteren Gastrointestinaltrakt schützt vor Infektionen im Op.-Gebiet – und dient darüber hinaus der besseren Sicht. Das bestätigt mit großer Robustheit eine randomisierte Studie im Fachblatt JAMA Surgery.

Chirurginnen und Chirurgen sind stark suizidgefährdet

07.05.2024 Suizid Nachrichten

Der belastende Arbeitsalltag wirkt sich negativ auf die psychische Gesundheit der Angehörigen ärztlicher Berufsgruppen aus. Chirurginnen und Chirurgen bilden da keine Ausnahme, im Gegenteil.

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Aktuelle BDC Leitlinien-Webinare

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

Karpaltunnelsyndrom BDC Leitlinien Webinare

CME: 2 Punkte

Das Karpaltunnelsyndrom ist die häufigste Kompressionsneuropathie peripherer Nerven. Obwohl die Anamnese mit dem nächtlichen Einschlafen der Hand (Brachialgia parästhetica nocturna) sehr typisch ist, ist eine klinisch-neurologische Untersuchung und Elektroneurografie in manchen Fällen auch eine Neurosonografie erforderlich. Im Anfangsstadium sind konservative Maßnahmen (Handgelenksschiene, Ergotherapie) empfehlenswert. Bei nicht Ansprechen der konservativen Therapie oder Auftreten von neurologischen Ausfällen ist eine Dekompression des N. medianus am Karpaltunnel indiziert.

Prof. Dr. med. Gregor Antoniadis

S2e-Leitlinie „Distale Radiusfraktur“

Radiusfraktur BDC Leitlinien Webinare

CME: 2 Punkte

Das Webinar beschäftigt sich mit Fragen und Antworten zu Diagnostik und Klassifikation sowie Möglichkeiten des Ausschlusses von Zusatzverletzungen. Die Referenten erläutern, welche Frakturen konservativ behandelt werden können und wie. Das Webinar beantwortet die Frage nach aktuellen operativen Therapiekonzepten: Welcher Zugang, welches Osteosynthesematerial? Auf was muss bei der Nachbehandlung der distalen Radiusfraktur geachtet werden?

PD Dr. med. Oliver Pieske

Dr. med. Benjamin Meyknecht

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“

Appendizitis BDC Leitlinien Webinare

CME: 2 Punkte

Inhalte des Webinars zur S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“ sind die Darstellung des Projektes und des Erstellungswegs zur S1-Leitlinie, die Erläuterung der klinischen Relevanz der Klassifikation EAES 2015, die wissenschaftliche Begründung der wichtigsten Empfehlungen und die Darstellung stadiengerechter Therapieoptionen.

Dr. med. Mihailo Andric

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 13/2023

Performance of a Nonlinear Magnetic Handheld Probe for Intraoperative Sentinel Lymph Node Detection: A Phantom Study

Impact of Sodium Thiosulfate on Prevention of Nephrotoxicities in HIPEC: An Ancillary Evaluation of Cisplatin-Induced Toxicities in Ovarian Cancer

Cryoablation Allows the Ultimate De-escalation of Surgical Therapy for Select Breast Cancer Patients

Great Debates: Neoadjuvant Therapy Should be Routinely Given for High-Risk Cholangiocarcinoma

ASO Author Reflections: CTCs in Patients with Gallbladder Adenocarcinoma

ASO Author Reflections: Contemporary Management of Low-Grade Appendiceal Mucinous Neoplasms

Update Chirurgie